University of Pisa
Pisa, Italy
I have been a member of the World Muscle Society since 1999 and I would be happy and honored to be part of the Executive Board of this Society, which best represents home valuing its members in their interests, initiatives, human and cultural interactions in the field and in which I find so many lovely friends and colleagues. I would eventually be proud to play a proactive role in the Executive Board of the WMS, contributing with the promotion of education, scientific exchange, dissemination of scientific and clinical experiences and results in National and International context. I have contributed in the past to the organizing committee for the WMS meeting in 2007 and, if liked, maybe pleased to bring again a next WMS Congress in Italy. I am for sure convinced that the cultural context within which WMS operates that enabled our community to reach in the last years key milestones in muscle diseases will be for me a strong commitment to hopefully achieve even more important goals in our fields.
Gabriele Siciliano, MD, PhD, FEAN Academic Neurologist
Current. Full Professor of Neurology and Director of the Residency Program in Neurology at the University of Pisa Medical School, Department of Clinical and Experimental Medicine, Neurological Clinic. Chair of Neurology and National Coordinating and Reference Centre for European Rare Disease Network Euro-NMD Ospedale S. Chiara, via Roma 67, 56126 Pisa (I). Tel.: +39050993604; fax: +39050554808; e-mail: g.siciliano@med.unipi.it
CV. Degree in Medicine, Unversity of Pisa (I), in 1980, 1983 Fellowship of Unione Italiana Lotta alla Distrofia Muscolare, 9 mo Neuropathology, University of Padova, argument: "Muscle histopathology in Neuromuscular Diseases", Specialist in Neurology in 1984, PhD at the University of Ancona (I) 1988..988 PhD Fellow, 6 mo, Laboratory of Neuropathology, University of Padova, argument: "Biochemistry investigations in the diagnosis of Neuromuscular Diseases"; 1989 PhD Fellow and "Guest Researcher”, 8 mo, Muscle Centre, Department of Medicine, Royal University Hospital, Liverpool (GB), argument: "Neurophysiopathologic techniques in the assessment of muscle fatigue in Neuromuscular Diseases". Specialist in Rehabilitation in 1992, in the same year Post-doc Fellow, 1 mo, Department of Biology, University of Padova, argument: "Methods of genetic and molecular analyses in the diagnosis of Muscular Dystrophies" and Post-doc Fellow and "Guest Researcher", 2 mo, Nuclear Magnetic Resonance Centre, University of Liverpool (GB), argument: "Magnetic Resonance Spectroscopic methods in the study of muscle function". 1999 Visiting researcher, Department of Neurology, Columbia University, New York (USA)Neurologist.
Assistant Register: at Neurological Clinic, University of Pisa, from 1993 to 1997. University Researcher Department of Neuroscience, University of Pisa from 1997 to 2001, University Associated Professor in Neurology (MED/26). Department of Clinical and Experimental Medicine, University of Pisa from 2001 to 2015, afterwards Full Professor of Neurology 2018- Director of the Residency School of Neurology- University of Pisa , Neurologist Assistant Register: at Neurological Clinic, University of Pisa, from 1993 to 1997. University Researcher from 1997 to 2001 and Associated Professor in Neurology at University of Pisa Medical School from 2001 to 2015, Full Professor of Neurology since 2016.
Clinical and Research. Since 1993 he is responsible for the Unit of Neuromuscular Diseases and for the Laboratory of Molecular Diagnosis in the former Department of Neuroscience, now Department of Clinical and Experimental Medicine – Neurological Clinics – University of Pisa, with main interests in clinical, laboratory and molecular aspects of neurodegenerative and neurogenetic disorders, acquired and genetic diseases of peripheral nervous system and skeletal muscle, conducted in collaboration with some overseas centres and laboratories. Firstly he studied as post-DOC several issues on muscle fatigue, in collaboration with the Muscle Research Centre, University of Liverpool, exercise in normal and myopathic subjects, motorneuron output evaluation in amyotrophic lateral sclerosis, subsarcolemmal excitability in myotonic syndromes and muscular dystrophies, analysis of metabolic parameters in McArdle’s disease and mitochondrial myopathies. He has been then engaged in numerous epidemiological, clinical genotype-phenotype correlation, natural history and therapeutic studies on neuromuscular disorders, in particular in muscular dystrophies, Steinert disease and other myotonic syndromes, mitochondrial myopathies, inflammatory peripheral neuropathies and amyotrophic lateral sclerosis.
D. Memberships in Scientific Societies
- Italian Society of Neurology, 1984- (Executive Board 2007-2011); Italian Association of Neuropathology, 1985- (Executive Board 2001-2004 and 2012-2015); Italian Society of Clinical Neurophysiology, 1989-; International Society of Neuropathology, 1990-;
- World Society of Neurology, dal 1990-; Royal Society of Medicine, Section of Neurology, 1991-2000;- World Society of Myology, 1996-;- Mediterranean Society of Myology, 2005- (Executive Board 2010-);- American Association for the Advancement of Science, 1998-2007;- Italian Association of Myology, since 2000- (Executive Board 2009-2015; Chairman 2015-2018);- Motorneurone Study Group of Italian Society of Neurology 2001- (National Coordinator 2003-2005);- European Amyotrophic Lateral Sclerosis Consortium, 2001-; Treat NMD since 2008; Euro-NMD ERN since 2017;
- European Federation of Neurological Societies, since 2012 and European Academy of Neurology since 2016 (Member since 2017, and Co-Chiar since 2019, of the Muscle and NMJ Disorders Scientific Panel).
Contributions to Science. All these activities have led to a scientific production of about 500 full papers, in peer reviewed international journals and cited in the most relevant bibliometric databases (H Index= 58, citation 15377 at Scopus) dealing with the above indicated arguments, by-law role in scientific and health system consulting organizations, coordination of funded projects from Institutional and Charity bodies, responsibility in research evaluation committees for public and private funding research bodies, participation to national and international clinical trials performed according to GCP.(last GCP training certificate obtained in 25 May 2022)..
